Raloxifene Clinical Trials

Raloxifene clinical trials studied its effectiveness in preventing and treating osteoporosis and reducing breast cancer risk in postmenopausal women. These studies showed that raloxifene helps protect bones from fractures, similar to estrogen, but without stimulating breast tissue or increasing the risk of blood clots. The trials compared raloxifene to placebos and other treatments, finding it effective and generally safe for women at risk of osteoporosis and breast cancer. Overall, the research supports raloxifene as a valuable option for bone health and breast cancer risk reduction in postmenopausal women.